What's New

2009

• Nationwide Public Health Alert Issued Concerning Life-Threatening Risk Posed by Cocaine Laced with Veterinary Anti-Parasite Drug, Posted September 2009
• A new Substance Abuse Treatment Advisory from SAMHSA, "Emerging Issues in the Use of Methadone", Posted September 2009
• Risk Management Webinar and Workshop, Posted July 2009
• SAMHSA notice of proposed rulemaking to remove time-in-treatment dispensing requirements for buprenorphine products used to treat patients in OTPs. The closing date for comments on this proposal is August 19, 2009. Federal Register Notice, Posted July 2009 (PDF, 327 KB)
• SAMHSA announces FY 2009 National All Schedules Prescription Electronic Reporting Act of 2005 (NASPER) request for applications, Posted July 2009 (PDF, 338 KB)
• Request for Comment on Minimum Requirements for Criteria in Grant Applications Under the National All Schedules Prescription Electronic Reporting Act of 2005 (NASPER), Federal Register Notice, Posted May 2009 (PDF, 74 KB)
• SAMHSA/FDA Public Education Campaign Targets Safe Use of Methadone, Posted April, 2009
• GAO Report: Methadone-associated overdose deaths. Factors Contributing to Increased Deaths and Efforts to Prevent Them, Posted March 2009

2008

• Opioid Treatment Program (OTP) Mortality Reporting Form. Posted November, 2008
• Summary Report of the Hepatitis A and B Vaccination Initiative. Posted November 2008 (PDF, 2.32 MB)
• FDA ALERT: Naltrexone Injection Site Reactions. Posted August 2008
• Hepatitis Infection in the Treatment of Opioid Dependence and Abuse. Posted June 2008
• SAMHSA guidance regarding labeling of take-home medication bottles. Posted May 2008 (PDF, 441 KB)
• Prescribing Courses: Clinical Challenges in Prescribing Controlled Drugs. Posted May, 2008
• Abuse, Addiction, and Pain Relief: Time for Change. CME Activity. Posted April, 2008
• Report of the Consultation and Debriefing Meeting on the Response to Fentanyl-Related Overdoses and Deaths, Washington, DC, August 2007 Posted April, 2008 (PDF, 330 KB)
• Restatement of SAMHSA guidance to OTPs on take-home doses when program closed for business (e.g., holidays) Posted January, 2008 (PDF, 149 KB)

2007

• As of January 1, 2008, distribution of methadone hydrochloride tablets, 40 mg (dispersible), will be limited to facilities authorized for detoxification and maintenance treatment of opioid addiction. Posted December, 2007 (PDF, 890 KB)
• Methadone Diversion, Abuse, and Misuse: Deaths Increasing at Alarming Rate. U.S. Dept of Justice, Drug Intelligence Center publication. Posted December, 2007
• Methadone Mortality Reassessment Meeting, Report (PDF, 426 KB)
• NASPER Report to Congress (DOC, 1.3 MB)
• Settlement in Federal Civil case against Maine Opioid Treatment Program (PDF, 64 KB)
• Final revised OTP Accreditation Guidelines Released
• New limit on number of buprenorphine patients per physician (PDF, 257 KB)

2006

• Methadone Public Health Advisory: New labeling
• Erratum for Treatment Improvement Protocol (TIP) 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs
• Institute of Medicine Report: Preventing HIV in Intravenous Drug Users
• CSAT announces Digital Access to Medication pilot project Website
• Heroin-Fentanyl fact sheet (PDF, 36 KB)
• Revised draft OTP Accreditation Guidelines released
• Draft 'Hepatitis in Opioid Addiction Treatment' guidelines (PDF, 7,350 KB)
• SAMHSA Hepatitis A and B (TWINRIX®) Vaccination Initiative
• OTPs may now submit patient exception requests on-line
• New Buprenorphine Group Practice Limit Eliminated (PDF, 33 KB)
• New DEA Regulations Implement Drug Addiction Treatment Act of 2000 (PDF, 157 KB)
• Methadone Associated Mortality: Report of a National Assessment

*PDF formatted files require that Adobe Acrobat Reader® program.
Follow this link to download this FREE software now from Adobe.